Petty, D and Khatib, R (2015) Dose optimisation following myocardial infarction. Prescriber, 26 (5). 29 - 31. ISSN 0959-6682
Abstract
Dose optimisation of medicines for secondary prevention of MI provides evidence-based benefits, but studies show that ACE inhibitors and beta-blockers are prescribed at suboptimal doses on discharge and are not appropriately up-titrated thereafter. Here we look at the reasons why and the possible solutions
Metadata
| Authors/Creators: |
|
|---|---|
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 06 Nov 2015 12:16 |
| Last Modified: | 06 Nov 2015 12:22 |
| Published Version: | http://dx.doi.org/10.1002/psb.1319 |
| Status: | Published |
| Publisher: | Wiley |
| Identification Number: | https://doi.org/10.1002/psb.1319 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)